Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $167M | $1.86B | -91.03% |
Cost of Revenue | $96M | $792M | -87.88% |
Operating Income | $-1.27B | $-366M | -245.90% |
Net Income | $-1.18B | $79M | -1587.34% |
EPS (Basic) | $-3.07 | $0.20 | -1635.00% |
EPS (Diluted) | $-3.07 | $0.19 | -1715.79% |
R&D Expense | $1.06B | $1.13B | -6.01% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $16.73B | $24.13B | -30.66% |
Current Assets | $9.6B | $12.12B | -20.81% |
Total Liabilities | $3.91B | $5.26B | -25.66% |
Current Liabilities | $2.38B | $3.5B | -31.98% |
Stockholders' Equity | $12.82B | $18.86B | -32.05% |
Cash & Equivalents | $2.05B | $3.44B | -40.40% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-989M | $-1.23B | +19.27% |
Investing Cash Flow | $118M | $2.01B | -94.13% |
Financing Cash Flow | $14M | $-542M | +102.58% |
Share Buybacks | $0 | $526M | -100.00% |
D&A | $35M | $78M | -55.13% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -758.1% | -19.7% | -738.43% |
Net Margin | -703.6% | — | — |
ROE | -9.2% | — | — |
ROA | -7.0% | — | — |
Current Ratio | $4.034 | — | — |
Debt to Equity | $0.305 | — | — |
Other companies in Biotechnology